Olive View-UCLA Medical Center

USA

Email: PCTP@ucla.edu

Qualifications

1996 Fellowship, University of California at Los Angeles, USA

1994 Residency, University of California at Los Angeles, USA

1991 M.D., University of California, USA

1987 B.Sc., Stanford University, USA

Publications (selected)

1. Pham PT, Edling K, Pham PC, Pham PM. Screening strategies and predictive tools for the development of new-onset diabetes after transplantation: an overview. Diabetes Metab Syn Obes 5:379-87, 2012.
2. Pham PT, Pham PC. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Nephrol Dialy Transpl 27(7):2965-2971, 2012.
3. Pham PA, Pham PT, Pham PC, et al. Implications of bleeding in acute coronary syndrome percutaneous coronary intervention. Vasc Health Risk Manag 7:551-567, 2011.
4. Pham PT, Pham PA, Pham PC, Parkh S, Danovitch G. Evaluation of adult kidney transplant candidates. Semin Dial: 23:595-605, 2010.
5. Pham PT, Pham PM, Pham SV, Pham PA, Pham PC. New onset diabetes after transplantation (NODAT): an overview. 4:175-186, 2011.
6. Pham PT, Pham PC. Immunosuppressive management of dialysis patients with recently failed transplants. Semin Dialy 24:307-313, 2011.
7. Pham PT, Pham PC. Graft loss due to recurrent lupus nephritis in living-related kidney donation. Clin J Am Soc Nephrol 6:2296-9, 2011.
8. Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV. Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention. Vasc Health Risk Manag 7:551-567, 2011.
9. Pham PT, Pham PC. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of graft loss due to glomerular disease recurrence. Nephrol Dial Transplant 2011.
10. Pham PT, Pham PA, Pham PC, Parikh S, Danovitch G. Evaluation of adult kidney transplant candidates. Semin Dial 23(6):595-605, 2010.
11. Pham PC, Dewar K, Hashmi S, Toscano E, Pham PM, Pham PA, Pham PT. Pain prevalence in patients with chronic kidney disease. Clin Nephrol 73(4)”294-299. 2010.
12. Pham PT, Lipschutz GS, Pham PT, Kawahji J, Singer JS, Pham PC. The evolving role of alemtuzumab (Campath-1H) in renal transplantation. Drug Des Devel Ther 3:41-9, 2009.
13. Pham PT, Slavov C, Pham PC. Acute kidney injury after liver, heart, and lung transplants: dialysis modality, predictors of renal function recovery, and impact on survival. Adv Chronic Kidney Dis 16(4):256-267, 2009.
14. Pham PT, Pham PC, Wilkinson AH. Management of renal dysfunction in the liver transplant recipient. Curr Opin Organ Transplant 14(3):231-239, 2009.

15. Pham PC, Pham PM, Pham PT, Pham SV, Pham PA, Pham PT. The link between hypomagnesemia and renal function in patients with diabetes mellitus type 2 deserves a better look. Clin Nephrol 71(April):375-379, 2009.